New data from Mary-Elizabeth Sheridan, Duale Ahmed and colleagues from the lab of Edana Cassol @carleton.ca - "Mitochondrial electron transport chain modulation orchestrates divergent #TLR3 and #TLR7 responses"
www.sciencedirect.com/science/arti...
"Shortly after vaccination, we observed increased expression of #TLR3 and #TLR9 in NK cells and markers such as CD69, HLA-DP-DQ-DR, CD38 and CD16."
Nuclear translocation of #TLR3 in #PancreaticDuctalAdenocarcinoma under #chemotherapy stress drives invasion, proliferation & #chemoresistance via JAK1/PRMT5/c-Myc axis, predicting poor prognosis and highlighting a novel therapeutic target in #cancer.
#STTT: doi.org/10.1038/s413...
Researchers identify nuclear translocation of #TLR3 under #chemotherapy stress drives PRMT5–c‑Myc signaling; high nuclear TLR3 predicts poor prognosis, highlighting the JAK1/TLR3/PRMT5/c‑Myc axis as a potential therapeutic target in #cancer.
#CoverPage #STTT: doi.org/10.1038/s413...
De novo design again 🤘 🧪 🖥️ #NoEmoji4Proteins #science #proteins #denovo #design #TLR3 www.nature.com/articles/s41...
Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways #EBV #CMV #KSHV #HSV1 #HSV2 #VZV #HHV6 #TLR2 #TLR3 #TLR4 #TLR5 #TLR7 #TLR9
bsky.app/profile/rene...
Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways #EBV #CMV #KSHV #HSV1 #HSV2 #VZV #HHV6 #TLR2 #TLR3 #TLR4 #TLR5 #TLR7 #TLR9
bsky.app/profile/rene...
Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways #EBV #CMV #KSHV #HSV1 #HSV2 #VZV #HHV6 #TLR2 #TLR3 #TLR4 #TLR5 #TLR7 #TLR9
virologyj.biomedcentral.com/track/pdf/10...
Ximena's review is out, congratulation!
Toll-Like Receptor 3 in #Solid #Cancer and #Therapy #Resistance
by Ximena Maria Muresan, Jan Bouchal, Zoran Culig and Karel Souček
👉
#TLR3
#dsRNA
#Cytokines
#therapyresistance
mdpi.com/2072-6694/12/1…